SG10201913752PA - Methods and compositions for stem cell transplantation - Google Patents
Methods and compositions for stem cell transplantationInfo
- Publication number
- SG10201913752PA SG10201913752PA SG10201913752PA SG10201913752PA SG10201913752PA SG 10201913752P A SG10201913752P A SG 10201913752PA SG 10201913752P A SG10201913752P A SG 10201913752PA SG 10201913752P A SG10201913752P A SG 10201913752PA SG 10201913752P A SG10201913752P A SG 10201913752PA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- stem cell
- cell transplantation
- transplantation
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000011476 stem cell transplantation Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562194460P | 2015-07-20 | 2015-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201913752PA true SG10201913752PA (en) | 2020-03-30 |
Family
ID=57834594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913752PA SG10201913752PA (en) | 2015-07-20 | 2016-07-19 | Methods and compositions for stem cell transplantation |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20180214488A1 (ru) |
| EP (2) | EP4202036A1 (ru) |
| JP (2) | JP7089282B2 (ru) |
| KR (1) | KR20180048617A (ru) |
| CN (1) | CN108350419A (ru) |
| AU (2) | AU2016297523B2 (ru) |
| DK (1) | DK3325612T3 (ru) |
| ES (1) | ES2939635T3 (ru) |
| FI (1) | FI3325612T3 (ru) |
| HK (1) | HK1258528A1 (ru) |
| RU (1) | RU2757818C2 (ru) |
| SG (1) | SG10201913752PA (ru) |
| WO (1) | WO2017015245A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1258452A1 (zh) * | 2015-07-20 | 2019-11-15 | Angiocrine Bioscience, Inc. | 表达ets转录因子的工程化的内皮细胞 |
| US12011488B2 (en) | 2016-03-23 | 2024-06-18 | The Regents Of The University Of California | Methods of treating mitochondrial disorders |
| AU2017237912B2 (en) | 2016-03-23 | 2022-03-10 | The Regents Of The University Of California | Methods of treating mitochondrial disorders |
| KR102458639B1 (ko) | 2016-09-13 | 2022-10-25 | 앤지오크린 바이오사이언스 인코포레이티드 | 조작된 내피 세포를 함유하는 혈액-뇌 장벽 |
| CA3056617A1 (en) * | 2017-03-15 | 2018-09-20 | The Regents Of The University Of California | Methods of treating lysosomal disorders |
| CN106929469B (zh) * | 2017-04-25 | 2020-08-07 | 徐子雁 | 间充质干细胞分化为表皮细胞的方法及试剂盒 |
| EP3768282A4 (en) * | 2018-03-23 | 2021-12-08 | The Children's Medical Center Corporation | ENDOTHELIAL CELL FACTORS AND RELATED PROCESSES |
| IL299456A (en) * | 2020-06-25 | 2023-02-01 | Angiocrine Bioscience Inc | Endothelial cells to reduce chemotherapy-induced toxicity |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE81724T1 (de) | 1987-11-09 | 1992-11-15 | Becton Dickinson Co | Verfahren zur analyse haematopoietischer zellen in einer probe. |
| US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
| US5840580A (en) | 1990-05-01 | 1998-11-24 | Becton Dickinson And Company | Phenotypic characterization of the hematopoietic stem cell |
| US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| DE4322570C1 (de) * | 1993-07-07 | 1994-06-16 | Gsf Forschungszentrum Umwelt | Stromale Zellinien aus menschlichem Knochenmark |
| US5599703A (en) * | 1993-10-28 | 1997-02-04 | The United States Of America As Represented By The Secretary Of The Navy | In vitro amplification/expansion of CD34+ stem and progenitor cells |
| US5925567A (en) | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
| US6335195B1 (en) | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| US6100086A (en) * | 1997-04-14 | 2000-08-08 | Genzyme Corporation | Transgene expression systems |
| WO2001052649A1 (en) | 2000-01-18 | 2001-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Expansion of stem and progenitor cells by beta-catenin |
| WO2002038189A1 (en) * | 2000-11-09 | 2002-05-16 | Mayo Foundation For Medical Education And Research | Absolute lymphocyte recovery and cancer survival |
| AU2002350030A1 (en) * | 2001-10-30 | 2003-05-12 | The United States Of America As Represented By The Secretary Of The Navy | Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury |
| US7635477B2 (en) * | 2002-07-25 | 2009-12-22 | The General Hospital Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| WO2008089448A2 (en) | 2007-01-19 | 2008-07-24 | Cornell Presearch Foundation, Inc. | Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis |
| EP2591093B1 (en) * | 2010-07-07 | 2018-11-28 | FUJIFILM Cellular Dynamics, Inc. | Endothelial cell production by programming |
| US20140030232A1 (en) * | 2010-08-12 | 2014-01-30 | Fate Therapeutics, Inc. | Hematopoietic stem and progenitor cell therapy |
| CN102643784B (zh) * | 2012-03-29 | 2016-05-25 | 中国人民解放军第四军医大学 | 一种造血干/祖细胞的体外扩增体系 |
| AU2013267422B2 (en) * | 2012-05-30 | 2018-07-26 | Cornell University | Generation of functional and durable endothelial cells from human amniotic fluid-derived cells |
| JP6581906B2 (ja) * | 2013-01-15 | 2019-09-25 | コーネル ユニヴァーシティー | 確定因子によるヒト内皮の造血性多系列前駆細胞へのリプログラミング |
| JP2015109833A (ja) | 2013-11-08 | 2015-06-18 | 学校法人慶應義塾 | 線維芽細胞から血管内皮細胞を製造する方法 |
| CA2964392A1 (en) * | 2014-10-31 | 2016-05-06 | Massachussetts Institute Of Technology | Delivery of biomolecules to immune cells |
| HK1258452A1 (zh) * | 2015-07-20 | 2019-11-15 | Angiocrine Bioscience, Inc. | 表达ets转录因子的工程化的内皮细胞 |
-
2016
- 2016-07-19 ES ES16828392T patent/ES2939635T3/es active Active
- 2016-07-19 HK HK19100883.9A patent/HK1258528A1/zh unknown
- 2016-07-19 KR KR1020187004650A patent/KR20180048617A/ko active Pending
- 2016-07-19 US US15/746,369 patent/US20180214488A1/en not_active Abandoned
- 2016-07-19 AU AU2016297523A patent/AU2016297523B2/en active Active
- 2016-07-19 FI FIEP16828392.7T patent/FI3325612T3/fi active
- 2016-07-19 JP JP2018503173A patent/JP7089282B2/ja active Active
- 2016-07-19 RU RU2018105988A patent/RU2757818C2/ru active
- 2016-07-19 CN CN201680053238.8A patent/CN108350419A/zh active Pending
- 2016-07-19 SG SG10201913752PA patent/SG10201913752PA/en unknown
- 2016-07-19 EP EP22206407.3A patent/EP4202036A1/en active Pending
- 2016-07-19 EP EP16828392.7A patent/EP3325612B1/en active Active
- 2016-07-19 DK DK16828392.7T patent/DK3325612T3/da active
- 2016-07-19 WO PCT/US2016/042872 patent/WO2017015245A1/en not_active Ceased
-
2022
- 2022-06-03 JP JP2022090788A patent/JP7473984B2/ja active Active
- 2022-07-07 AU AU2022204899A patent/AU2022204899A1/en not_active Abandoned
-
2023
- 2023-09-11 US US18/464,908 patent/US20230414671A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2939635T3 (es) | 2023-04-25 |
| JP7473984B2 (ja) | 2024-04-24 |
| AU2016297523B2 (en) | 2022-07-28 |
| EP4202036A1 (en) | 2023-06-28 |
| WO2017015245A8 (en) | 2022-11-03 |
| CA2993014A1 (en) | 2017-01-26 |
| HK1258528A1 (zh) | 2019-11-15 |
| AU2016297523A1 (en) | 2018-02-22 |
| KR20180048617A (ko) | 2018-05-10 |
| JP2018521074A (ja) | 2018-08-02 |
| JP7089282B2 (ja) | 2022-06-22 |
| AU2022204899A1 (en) | 2022-07-28 |
| RU2757818C2 (ru) | 2021-10-21 |
| US20180214488A1 (en) | 2018-08-02 |
| RU2018105988A3 (ru) | 2020-01-21 |
| JP2022121446A (ja) | 2022-08-19 |
| CN108350419A (zh) | 2018-07-31 |
| EP3325612B1 (en) | 2022-12-14 |
| EP3325612A1 (en) | 2018-05-30 |
| US20230414671A1 (en) | 2023-12-28 |
| FI3325612T3 (fi) | 2023-03-20 |
| DK3325612T3 (da) | 2023-03-06 |
| RU2018105988A (ru) | 2019-08-20 |
| EP3325612A4 (en) | 2018-12-26 |
| WO2017015245A1 (en) | 2017-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259576A (en) | Preparations and methods for immuno-oncology | |
| IL251951A0 (en) | Methods and compositions for natural killer cells | |
| EP3331582A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TRANSPLANTATION CELLS | |
| IL250689B (en) | Rearrangement of multipurpose stem cells | |
| IL251576A0 (en) | Methods and compositions for creating or maintaining multifunctional cells | |
| IL250132A0 (en) | A method to induce t-cell immunocytotherapy from stem cell potential | |
| EP3212225A4 (en) | Methods and compositions for modified t cells | |
| EP3019596A4 (en) | Compositions and methods for reprograming non- pluripotent cells into pluripotent stem cells | |
| EP3230460A4 (en) | Methods and compositions for selectively eliminating cells of interest | |
| IL257678A (en) | Methods of stem cell transplantation | |
| SG11201607925SA (en) | Improved stem cell composition | |
| IL255480B (en) | Preparations containing mesenchymal stem cells and their uses | |
| SG10201913752PA (en) | Methods and compositions for stem cell transplantation | |
| IL246879A0 (en) | Preparations of Epilimod and methods of using them | |
| PL3586821T3 (pl) | Kompozycje stymulujące komórki macierzyste i sposoby | |
| EP3383182C0 (en) | METHODS FOR PRODUCING FUNCTIONAL HEMATOPOIETIC STEM CELLS | |
| IL277878A (en) | Preparations and methods for stem cell transplantation | |
| EP3139913A4 (en) | Methods and compositions for non-cytotoxic stem cell transplantation | |
| SG11201703512QA (en) | Medium composition for culturing stem cells | |
| SG11201702475VA (en) | Methods and compositions for modulating th-gm cell function | |
| EP3134096A4 (en) | Methods of enhancing stem cell engraftment | |
| IL258242B (en) | Preparations and methods for inhibiting cancer stem cells | |
| PL3638021T3 (pl) | Sposoby konserwacji komórek | |
| SG10201403640XA (en) | Stem cells | |
| SG11201800503YA (en) | Stem cell culturing method |